Keith T Flaherty

81PUBLICATIONS
596CO-AUTHORS
Gene and molecular therapyMolecular targetsPredictive and prognostic markersImmunogenetics (incl. genetic immunology)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (81)

|Aug 12, 2026
COMBI-I: Long-Term Overall Survival With Spartalizumab Plus Dabrafenib and Trametinib in BRAF V600-Mutant Advanced Melanoma.

|Aug 11, 2026
ERK1/2 Inhibitor Ulixertinib in Pan-cancer Patients with BRAF Fusions or Non-V600E/K Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1L.

|Aug 07, 2026
Associations of Age With Tumor Genomic Characteristics in Relapsed/Refractory Cancers Interrogated With the NCI-MATCH Trial Targeted Gene Panel Assay.

|Jun 24, 2026
Multimodal blood based proteomic profiling reveals insights into mechanisms of immunotherapy resistance.

|Jun 17, 2026
Phase II Study of Adavosertib in Patients With Tumors Containing BRCA1 and BRCA2 Mutations: Results From the NCI-MATCH ECOG-ACRIN Cancer Research Group (EAY131) Subprotocol Z1I.

|May 25, 2026
Genomic, Clinical, and Spatial Predictors of Durable Response to BRAF/MEK Inhibition in BRAF-Mutant Melanoma.

Pageof 14

Frequent Collaborators

27 joint publications

Lisa M McShane

27 joint publications

Stanley R Hamilton

25 joint publications

David R Patton

24 joint publications

Robert J Gray